Nifty

:

22368.00

Sensex

:

73738.45

31.60 (0.14%)
650.12 (0.89%)

Login

Nifty
Sensex

:
:

22368.00
73738.45

31.60 (0.14%)
650.12 (0.89%)

Sakar Healthcare Ltd.

Pharmaceuticals & Drugs

Rating :

54/99

BSE: Not Listed | NSE: SAKAR

Watchlist

NSE BSE

359.90

23-Apr-2024

Open
High
Low
Previous Close

359.95
367.90
357.30
358.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

11618
42.20
479.00
210.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

779.30
62.49
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

847.42
N/A
3.03

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

16.21
14.34
12.07

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.57
14.56
8.03

PAT CAGR (%)

10 Years
5 Years
3 Years

21.98
13.78
6.11

P:E (Median)

8 Years
5 Years
3 Years

-
-
31.30

P:BV (Average)

8 Years
5 Years
3 Years

-
-
2.75

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
15.72

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 37.23 33.46 11.27% 34.08 30.71 10.97% 38.99 28.53 36.66% 40.65 36.59 11.10%
Expenses 28.22 24.66 14.44% 24.72 22.11 11.80% 29.96 20.58 45.58% 32.87 27.41 19.92%
EBITDA 9.01 8.80 2.39% 9.36 8.60 8.84% 9.03 7.96 13.44% 7.78 9.18 -15.25%
EBIDTM 24.20% 26.30% -141.38% -141.38% 23.15% 27.89% 19.15% 25.08%
Other Income 0.23 1.85 -87.57% 0.66 0.60 10.00% 1.52 0.41 270.73% 1.82 0.88 106.82%
Interest 1.79 1.94 -7.73% 1.65 0.99 66.67% 2.08 0.86 141.86% 2.15 0.68 216.18%
Depreciation 4.45 4.10 8.54% 4.22 3.77 11.94% 4.52 3.57 26.61% 3.55 3.19 11.29%
PBT 3.00 4.61 -34.92% 4.15 4.44 -6.53% 3.95 3.94 0.25% 3.89 6.19 -37.16%
Tax 0.93 0.60 55.00% 0.52 2.49 -79.12% 1.11 1.06 4.72% -0.03 -2.82 -
PAT 2.07 4.01 -48.38% 3.64 1.94 87.63% 2.84 2.88 -1.39% 3.92 9.01 -56.49%
PATM 5.57% 11.99% 56.25% 56.25% 7.29% 10.09% 9.65% 24.63%
EPS 0.96 1.85 -48.11% 1.68 0.90 86.67% 1.31 1.33 -1.50% 1.81 4.15 -56.39%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 37.23 33.46 11.27% 34.08 30.71 10.97% 38.99 28.53 36.66% 40.65 36.59 11.10%
Expenses 28.22 24.66 14.44% 24.72 22.11 11.80% 29.96 20.58 45.58% 32.87 27.49 19.57%
EBITDA 9.01 8.80 2.39% 9.36 8.60 8.84% 9.03 7.96 13.44% 7.78 9.10 -14.51%
EBIDTM 24.20% 26.30% -4.88% -4.88% 23.15% 27.89% 19.15% 24.88%
Other Income 0.23 1.85 -87.57% 0.66 0.60 10.00% 1.52 0.41 270.73% 1.82 0.88 106.82%
Interest 1.79 1.94 -7.73% 1.65 0.99 66.67% 2.08 0.86 141.86% 2.15 0.68 216.18%
Depreciation 4.45 4.10 8.54% 4.22 3.77 11.94% 4.52 3.57 26.61% 3.55 3.19 11.29%
PBT 3.00 4.61 -34.92% 4.15 4.44 -6.53% 3.95 3.94 0.25% 3.89 6.11 -36.33%
Tax 0.93 0.60 55.00% 0.52 2.49 -79.12% 1.11 1.06 4.72% -0.03 -2.84 -
PAT 2.07 4.01 -48.38% 3.64 1.94 87.63% 2.84 2.88 -1.39% 3.92 8.95 -56.20%
PATM 5.57% 11.99% -10.84% -10.84% 7.29% 10.09% 9.65% 24.46%
EPS 0.95 2.16 -56.02% -0.96 -0.96 - 1.49 1.68 -11.31% 2.06 5.23 -60.61%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 150.95 133.36 128.23 94.74 82.98 68.25 53.08 44.17 41.23 35.03 29.69 Net Sales Growth 16.75% 4.00% 35.35% 14.17% 21.58% 28.58% 20.17% 7.13% 17.70% 17.99% Cost Of Goods Sold 65.29 73.54 74.42 51.11 43.05 35.41 28.00 22.29 21.97 17.33 13.23 Gross Profit 85.66 59.81 53.80 43.63 39.93 32.84 25.08 21.89 19.26 17.69 16.46 GP Margin 56.75% 44.85% 41.96% 46.05% 48.12% 48.12% 47.25% 49.56% 46.71% 50.50% 55.44% Total Expenditure 115.77 100.09 98.81 72.12 63.43 51.39 40.50 34.01 32.88 27.16 21.86 Power & Fuel Cost - 2.90 3.01 2.26 3.31 3.23 2.43 2.43 3.23 3.27 2.88 % Of Sales - 2.17% 2.35% 2.39% 3.99% 4.73% 4.58% 5.50% 7.83% 9.33% 9.70% Employee Cost - 15.81 14.26 12.74 11.61 8.45 6.55 5.64 4.49 3.80 3.03 % Of Sales - 11.86% 11.12% 13.45% 13.99% 12.38% 12.34% 12.77% 10.89% 10.85% 10.21% Manufacturing Exp. - 0.81 1.24 1.20 1.64 1.02 0.76 0.62 0.88 0.74 0.85 % Of Sales - 0.61% 0.97% 1.27% 1.98% 1.49% 1.43% 1.40% 2.13% 2.11% 2.86% General & Admin Exp. - 3.65 3.36 2.86 2.68 2.13 2.01 2.40 1.60 1.89 1.75 % Of Sales - 2.74% 2.62% 3.02% 3.23% 3.12% 3.79% 5.43% 3.88% 5.40% 5.89% Selling & Distn. Exp. - 3.06 2.37 1.33 1.10 1.13 0.69 0.63 0.63 0.12 0.12 % Of Sales - 2.29% 1.85% 1.40% 1.33% 1.66% 1.30% 1.43% 1.53% 0.34% 0.40% Miscellaneous Exp. - 0.32 0.15 0.63 0.04 0.02 0.06 0.00 0.09 0.00 0.12 % Of Sales - 0.24% 0.12% 0.66% 0.05% 0.03% 0.11% 0% 0.22% 0% 0% EBITDA 35.18 33.27 29.42 22.62 19.55 16.86 12.58 10.16 8.35 7.87 7.83 EBITDA Margin 23.31% 24.95% 22.94% 23.88% 23.56% 24.70% 23.70% 23.00% 20.25% 22.47% 26.37% Other Income 4.23 4.67 2.17 1.18 2.02 0.68 0.53 0.73 0.21 0.03 0.04 Interest 7.67 5.96 2.91 2.49 2.26 2.27 2.59 2.69 2.94 2.99 3.75 Depreciation 16.74 14.99 9.67 8.06 7.08 6.04 4.41 3.39 2.73 2.50 2.12 PBT 14.99 17.00 19.01 13.24 12.23 9.23 6.11 4.82 2.88 2.42 2.00 Tax 2.53 4.23 3.77 2.55 2.60 2.54 2.29 1.44 0.55 0.58 0.25 Tax Rate 16.88% 24.90% 19.83% 19.26% 21.26% 27.52% 37.48% 29.88% 19.10% 23.97% 12.50% PAT 12.47 12.76 15.24 10.69 9.62 6.69 3.81 3.38 2.33 1.84 1.75 PAT before Minority Interest 12.47 12.76 15.24 10.69 9.62 6.69 3.81 3.38 2.33 1.84 1.75 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.26% 9.57% 11.88% 11.28% 11.59% 9.80% 7.18% 7.65% 5.65% 5.25% 5.89% PAT Growth -30.10% -16.27% 42.56% 11.12% 43.80% 75.59% 12.72% 45.06% 26.63% 5.14% EPS 5.75 5.88 7.02 4.93 4.43 3.08 1.76 1.56 1.07 0.85 0.81

Description TTM Mar 23 Mar 22 Mar 21 Mar 20
Net Sales 150.95 133.36 128.23 94.74 82.98 Net Sales Growth 16.75% 4.00% 35.35% 14.17% Cost Of Goods Sold 1,065.86 73.54 74.42 51.11 43.05 Gross Profit -914.91 59.81 53.80 43.63 39.93 GP Margin -606.10% 44.85% 41.96% 46.05% 48.12% Total Expenditure 115.77 100.09 98.89 72.13 63.43 Power & Fuel Cost - 2.90 3.01 2.26 3.31 % Of Sales - 2.17% 2.35% 2.39% 3.99% Employee Cost - 15.81 14.26 12.74 11.61 % Of Sales - 11.86% 11.12% 13.45% 13.99% Manufacturing Exp. - 0.81 1.24 1.20 1.64 % Of Sales - 0.61% 0.97% 1.27% 1.98% General & Admin Exp. - 3.65 3.43 2.87 2.68 % Of Sales - 2.74% 2.67% 3.03% 3.23% Selling & Distn. Exp. - 3.06 2.38 1.33 1.10 % Of Sales - 2.29% 1.86% 1.40% 1.33% Miscellaneous Exp. - 0.32 0.15 0.61 0.04 % Of Sales - 0.24% 0.12% 0.64% 0.05% EBITDA 35.18 33.27 29.34 22.61 19.55 EBITDA Margin 23.31% 24.95% 22.88% 23.87% 23.56% Other Income 4.23 4.67 2.17 1.18 2.02 Interest 7.67 5.96 2.91 2.49 2.26 Depreciation 16.74 14.99 9.67 8.06 7.08 PBT 14.99 17.00 18.93 13.23 12.23 Tax 2.53 4.23 3.75 2.55 2.60 Tax Rate 16.88% 24.90% 19.81% 19.27% 21.26% PAT 12.47 12.76 15.18 10.68 9.62 PAT before Minority Interest 12.20 12.76 15.18 10.68 9.62 Minority Interest -0.27 0.00 0.00 0.00 0.00 PAT Margin 8.26% 9.57% 11.84% 11.27% 11.59% PAT Growth -29.87% -15.94% 42.13% 11.02% EPS 5.75 5.88 7.00 4.92 4.43

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 173.43 127.54 98.46 81.32 71.73 51.49 35.50 17.16 14.83 13.87 Share Capital 19.04 17.12 15.62 14.96 14.96 12.21 10.96 8.00 8.00 8.00 Total Reserves 154.39 110.42 82.84 66.36 56.77 34.61 24.54 9.16 6.83 4.99 Non-Current Liabilities 108.50 93.54 46.07 19.57 11.76 16.82 22.36 21.75 25.11 23.87 Secured Loans 93.17 79.93 35.04 8.79 1.57 4.69 8.10 8.06 11.02 13.50 Unsecured Loans 5.05 5.07 3.41 3.68 3.64 5.15 7.81 7.36 7.76 4.10 Long Term Provisions 1.70 1.44 0.79 0.70 0.47 0.00 0.00 0.00 0.00 0.00 Current Liabilities 54.49 46.78 33.27 14.24 13.88 12.79 12.73 12.20 10.23 14.60 Trade Payables 26.09 30.50 19.78 5.44 3.99 4.41 3.10 3.98 0.96 3.52 Other Current Liabilities 13.58 8.57 8.82 4.98 5.12 5.84 3.96 3.99 2.92 4.14 Short Term Borrowings 13.02 4.52 1.69 2.26 2.73 1.37 5.32 3.91 5.97 6.72 Short Term Provisions 1.80 3.19 2.97 1.55 2.04 1.17 0.34 0.32 0.38 0.22 Total Liabilities 336.42 267.86 177.80 115.13 97.37 81.10 70.59 51.11 50.17 52.34 Net Block 266.64 204.65 69.10 65.69 63.54 53.33 48.93 37.25 36.18 38.01 Gross Block 304.99 235.50 90.28 78.81 69.58 76.47 67.66 52.59 48.79 48.12 Accumulated Depreciation 38.35 30.84 21.18 13.12 6.04 23.14 18.73 15.34 12.61 10.11 Non Current Assets 280.43 217.75 144.00 93.47 77.33 53.68 49.36 37.53 36.47 38.29 Capital Work in Progress 6.45 1.23 48.92 13.10 8.66 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 7.33 11.86 25.97 14.68 5.13 0.35 0.43 0.28 0.28 0.28 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 55.99 50.10 33.80 21.65 20.06 27.42 21.23 13.58 13.71 14.04 Current Investments 3.43 7.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 15.40 14.18 15.70 10.93 6.86 3.93 6.96 6.45 6.74 6.87 Sundry Debtors 22.08 14.18 12.37 8.23 9.50 10.82 5.35 2.98 2.01 2.25 Cash & Bank 0.09 0.03 0.08 0.30 0.37 0.36 0.45 0.23 0.93 0.09 Other Current Assets 15.00 0.22 0.09 0.08 3.33 12.31 8.47 3.92 4.03 4.83 Short Term Loans & Adv. 14.54 14.38 5.56 2.11 3.26 8.75 5.44 3.27 3.31 4.32 Net Current Assets 1.50 3.32 0.53 7.41 6.17 14.63 8.50 1.38 3.48 -0.55 Total Assets 336.42 267.85 177.80 115.12 97.39 81.10 70.59 51.11 50.18 52.33

Description Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 173.35 127.45 98.45 81.32 Share Capital 19.04 17.12 15.62 14.96 Total Reserves 154.31 110.33 82.83 66.36 Non-Current Liabilities 108.50 93.54 46.07 19.57 Secured Loans 93.17 79.93 35.04 8.79 Unsecured Loans 5.05 5.07 3.41 3.68 Long Term Provisions 1.70 1.44 0.79 0.70 Current Liabilities 54.49 46.78 33.27 14.15 Trade Payables 26.09 30.50 19.78 5.44 Other Current Liabilities 13.58 8.57 8.82 4.98 Short Term Borrowings 13.02 4.52 1.69 2.18 Short Term Provisions 1.80 3.19 2.97 1.55 Total Liabilities 336.34 267.77 177.79 115.04 Net Block 266.64 204.65 69.10 65.69 Gross Block 304.99 235.50 90.28 78.81 Accumulated Depreciation 38.35 30.84 21.18 13.12 Non Current Assets 280.42 217.74 144.07 93.46 Capital Work in Progress 6.45 1.23 48.92 13.10 Non Current Investment 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 7.33 11.86 26.05 14.68 Other Non Current Assets 0.00 0.00 0.00 0.00 Current Assets 55.92 50.02 33.72 21.58 Current Investments 3.43 7.11 0.00 0.00 Inventories 15.40 14.18 15.70 10.93 Sundry Debtors 22.08 14.18 12.37 8.23 Cash & Bank 0.09 0.03 0.08 0.30 Other Current Assets 14.92 0.22 0.09 0.08 Short Term Loans & Adv. 14.46 14.30 5.48 2.04 Net Current Assets 1.42 3.25 0.45 7.42 Total Assets 336.34 267.76 177.79 115.04

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 33.34 35.79 14.58 18.79 16.14 5.26 9.19 9.19 4.18 8.57 PBT 16.88 19.01 13.24 12.23 9.23 6.11 2.86 2.88 2.42 2.00 Adjustment 20.14 12.50 8.90 9.19 8.09 6.46 5.46 5.46 5.46 6.24 Changes in Working Capital 0.60 4.09 -6.83 0.15 0.21 -6.14 1.41 1.39 -3.19 0.74 Cash after chg. in Working capital 37.61 35.60 15.31 21.56 17.54 6.43 9.74 9.74 4.69 8.98 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.27 0.19 -0.73 -2.77 -1.40 -1.16 -0.55 -0.55 -0.51 -0.42 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -74.38 -90.40 -46.83 -22.34 -24.91 -8.28 -3.59 -3.59 -0.64 -2.70 Net Fixed Assets -74.71 -97.53 -47.29 -13.67 -1.77 -8.81 -15.07 -3.80 -0.67 -2.72 Net Investments 3.68 -7.11 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 Others -3.35 14.24 0.46 -8.66 -23.14 0.53 11.48 0.21 0.03 0.02 Cash from Financing Activity 41.10 54.56 32.03 3.48 8.77 -12.99 -6.30 -6.30 -2.69 -5.95 Net Cash Inflow / Outflow 0.06 -0.05 -0.22 -0.07 0.00 -16.01 -0.70 -0.70 0.84 -0.08 Opening Cash & Equivalents 0.03 0.08 0.30 0.37 0.36 0.45 0.93 0.93 0.09 0.17 Closing Cash & Equivalent 0.09 0.03 0.08 0.30 0.37 -15.55 0.23 0.23 0.93 0.09

Description Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 33.34 35.70 14.58 18.86 PBT 16.88 18.93 13.23 12.23 Adjustment 20.14 12.50 8.90 9.19 Changes in Working Capital 0.60 4.09 -6.83 0.22 Cash after chg. in Working capital 37.61 35.52 15.30 21.64 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -4.27 0.18 -0.73 -2.77 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -74.38 -90.37 -46.83 -22.41 Net Fixed Assets -74.71 -97.53 -47.29 Net Investments 3.68 -7.11 0.00 Others -3.35 14.27 0.46 Cash from Financing Activity 41.10 54.62 32.03 3.48 Net Cash Inflow / Outflow 0.06 -0.05 -0.22 -0.06 Opening Cash & Equivalents 0.03 0.08 0.31 0.37 Closing Cash & Equivalent 0.09 0.03 0.08 0.31

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 91.09 74.50 63.04 54.35 47.95 38.34 32.39 21.45 18.53 16.24 ROA 4.22% 6.84% 7.30% 9.06% 7.50% 5.03% 5.55% 4.60% 3.58% 3.42% ROE 8.48% 13.49% 11.89% 12.57% 11.29% 9.27% 12.83% 14.56% 13.20% 14.46% ROCE 8.95% 12.13% 13.16% 16.02% 15.45% 14.17% 16.11% 15.29% 13.89% 14.87% Fixed Asset Turnover 0.49 0.79 1.12 1.12 0.93 0.74 0.73 0.81 0.72 0.63 Receivable days 49.62 37.80 39.70 39.01 54.34 55.58 34.38 22.05 22.17 22.10 Inventory Days 40.48 42.53 51.30 39.13 28.85 37.44 55.38 58.37 70.92 82.26 Payable days 140.43 123.30 90.05 39.98 27.49 32.33 35.98 26.35 28.28 49.97 Cash Conversion Cycle -50.33 -42.97 0.95 38.16 55.69 60.69 53.79 54.07 64.81 54.40 Total Debt/Equity 0.69 0.73 0.43 0.21 0.16 0.31 0.60 1.13 1.67 1.87 Interest Cover 3.85 7.53 6.31 6.41 5.07 3.36 2.79 1.98 1.81 1.53

Description Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 91.04 74.45 63.04 54.35 ROA 4.22% 6.81% 7.30% 8.36% ROE 8.48% 13.44% 11.88% 11.83% ROCE 8.95% 12.09% 13.16% 14.79% Fixed Asset Turnover 0.49 0.79 1.12 1.05 Receivable days 49.62 37.80 39.70 36.22 Inventory Days 40.48 42.53 51.30 48.09 Payable days 140.43 123.30 90.05 46.13 Cash Conversion Cycle -50.33 -42.97 0.95 38.18 Total Debt/Equity 0.69 0.73 0.43 0.20 Interest Cover 3.85 7.51 6.30 6.41

Top Investors:

tata capital healthcare fund ii

hbm healthcare investments (cayman) ltd

cobra india (mauritius) limited

subhash phootarmal rathod

hi-tech chemicals limited

Annual Reports:

News Update:

Sakar Healthcare - Quarterly Results
10th Feb 2024, 12:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback